Clinical Trial Update: Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dabigatran to phenprocoumon for left atrial thrombus reduction in atrial fibrillation; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Left Atrial Thrombosis

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Phenprocoumon (phenprocoumon)

Snippet

Sponsor: University of Ulm | Conditions: Atrial Fibrillation, Left Atrial Thrombosis | Phase 4 | Status: UNKNOWN